Director, Market Access Payer Accounts - Northeast

The posting, as Summit Therapeutics wrote it

About Summit

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Location : Remote - Field based. Candidates should be based in one of the following states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York or Pennsylvania.

Overview of Role

The Director of Market Access Payer Account at Summit Therapeutics reports directly to the Executive Director, Payer Strategic Accounts, and will be responsible for leadership and management of select national and sub-national payers and other assigned accounts. This is a critical customer-facing role helping to ensure broad access, reimbursement, and patient affordability. These accounts include, National/Regional Health Plans, PBMs, Medicare, state Medicaid, VA/DoD, among others.

The Director will be responsible for building and maintaining strong relationships with decision makers within the accounts, including medical and pharmacy departments. This role involves executing strategies and tactics within each account, while also providing support to the regional field matrix teams when n
[…]
d; advanced degree preferred.

• Minimum of 10+ years biotech/pharmaceutical experience
• Minimum of 5+ years of focused account management experience in the oncology access marketplace
• Demonstrated success in engaging with US payers, MACs, PBMs, and IDNs
• Strong understanding of the US healthcare payer/access landscape and regulatory environment
• Excellent strategic thinking, leadership, negotiation, and relationship management skills
• Ability to work on cross-functional teams and drive complex projects to completion
• Exceptional communication and presentation skills
• Successful record of achieving and maintaining compliance with all applicable regulatory, legal, and operational rules
• Travel: Ability to travel to support business priorities as needed

This is the pay for this position

Pay Transparency
$197,000 — $246,500 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.